Press Release: Sanofi’s venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher disease

Sanofi’s venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher diseaseIn the LEAP2MONO phase 3 study, venglustat, dosed ...

Sanofi: Sanofi's venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher disease

Sanofi's venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher disease In the LEAP2MONO phase 3 study, venglustat, dosed orally once daily, demonstrated clinically meaningful effic ...
The New Times on MSN

What excess of nutritional supplements can do

With increasing affluence and awareness about health, many well-off people have started taking nutritional supplements such as vitamins, and proteins, and even give them to their growing children.